Competition, Licensing-in and Innovation

Working Papers

The study explores how pursuing radical innovations shapes market values and hence performance expectations for young startup firms. It departs from the typical emphasis on the advantages of startups “attacking” established firms and considers a setting in which established firms maintain control of critical downstream complementary assets.Read More

Standard vs. Partnership-Embedded Licensing: Attention and the Relationship Between Licensing and Product Innovations

Published Research

This paper examines the relationship between the licensing of knowledge and the creation of product innovations. We consider that firms organize licensing activities in different ways and that licensees are heterogeneous with respect to the attention available to apply and transform in-licensed knowledge to create new product innovations. Read More

Challenges in the Gene Therapy Commercial Ecosystem

Published Research

The emergence of biotech has resulted in a rich ecosystem of different types of actors contributing to the technological advance. Despite the enormous promise of biotech-based therapeutics, there is substantial uncertainty regarding when scientific discoveries will emerge, whether these discoveries will achieve clinical success, and how commercialized treatments will create value. Read More

Which Industries are Served by Online Markets for Technology?

Published Research

This study investigates a recent phenomenon in the market for technology: online marketplaces for technological inventions, which support the listing, search, and exchange of technological inventions by sellers and buyers. Focusing on three salient theoretical factors that affect markets for technology—search costs, ambiguity about the underlying knowledge and its applications, and expropriation concerns—our research systematically explores which industries are served by online marketplaces.Read More

How Are Established Companies Sourcing External Knowledge? Evidence From The Global Bio-Pharmaceutical Industry

Working Papers

Emerging markets firms in high-technology industries have long been thought of as laggards. We argue that this paradigm needs to be reassessed. Using biotechnology as an example for a radical technology we argue that emerging market, compared to developed markets, are well positioned to pursue such technologies.Read More

How Does Performance Feedback Affect Boundary Spanning in Multinational Corporations? Insights from Technology Scouts

Published Research

As much as prior research has shed light on the boundary-spanning processes of global organizations and their (positive) impact on an MNC’s performance, whether, when and how past performance ultimately shapes an MNC’s boundary-spanning activities remains an open question in management research.Read More

Decoding the Adaptability-Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies

Published Research

The emergence of radical technologies presents a significant challenge to incumbent firms. We study firms’ management of radical technological change by separating their actions into upstream research (“R” of R&D) and downstream development (“D” of R&D).Read More

Opening Up but Staying Local: Insights from Partnership Formations between Established and Startup Firms

Working Papers

In this paper, we develop a theoretical framework that considers that firms may be subject to both spatial and temporal myopia when crossing organizational boundaries and have a history of failures and successes in solving R&D problems. We use this framework to clarify how established firms search for and select among emerging partnering opportunities.Read More